Skip to main content

Table 1 Sex ratio and mean age in the different clinical groups after allocation of patients and controls according to Rome II FGID groups[5]and Fukuda CDC criteria[34]for the three analysis categorizations used in the present study

From: Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome

    

Breakdown into recruited groups

 

Age (mean (SD))

Females (%)

Total participants, n

Exposed patients, fatigue at 3 years, n

Exposed controls, no fatigue at 3 years, n

Unexposed, healthy controls, n

Fatigue categorization

      

 no-fatigue

40.9 (11.7)

72

32

0

22

10

 CFS

45.5 (9.1)

79

19

19

0

0

 ICF

37.8 (8.9)

80

5

5

0

0

 Fatigue other cause

45.5 (15.2)

100

12

12

0

0

 Fatigue recovered

36.0 (9.6)

58

12

12

0

0

FGID categorization

      

 no-FGID

41.8 (13.2)

78

26

5

11

10

 All FGID

41.4 (10.8)

76

54

43

11

0

   PI-FGID

40.8 (10.2)

76

45

36

9

0

  IBS

41.7 (10.4)

80

30

27

3

0

   PI-IBS

40.4 (10.4)

79

24

22

2

0

  Other FGID

41.1 (11.5)

71

24

16

8

0

Combined categorization

      

 no-FGID/no-fatigue

39.9 (12.5)

74

23

2

11

10

 FGID&CFS/ICF

44.3 (9.4)

78

23

23

0

0

 CFS, no-FGID

35.0

100

1

1

0

0

 FGID, no-fatigue

39.1 (10.1)

62

21

10

11

0

 Fatigue other cause w/wo FGID

45.5 (11.5)

100

12

12

0

0

  1. Abbreviations: CFS: chronic fatigue syndrome, FGID: functional gastrointestinal disorder, ICF: idiopathic chronic fatigue, IBS: irritable bowel syndrome, PI: post-infectious.
  2. Subgroups of interest within each group are indicated by indents.